Companies and AI developments
Updates
Daily market commentary, company analyses, investment stories and AI news. Price-only updates require a cumulative move of greater than 15% from the last published assessment. Newest first.
News from the Singularity The Lean and Mathlib communities certified Levent Alpöge’s formal proof of the Riemann Hypothesis. Other topics: offensive agents targeting MONAI Label, plus Friday context on local Inkling deployment and Oracle financing. Read article →
News from the Singularity Anthropic announced the closing of its IPO and private placement. METR’s new report shows rapidly growing measured capabilities alongside weaker judgment; Google expands agent oversight and explains calling through Gemini. Read article →
Optimistic scenario If UnitedHealth restores pricing discipline, moves OptumHealth toward its 6–8% long-term margin and keeps regulatory costs under control, normalized 2029 earnings could reach roughly USD 30 per share. This is ChatGPT’s conditional optimistic scenario, not a base-case forecast. Read article →
The lower USD 29.51 entry price raises price attractiveness to 4.6/10 under unchanged cases. Conference disclosures add Athena usage, pipeline and Palantir Foundry integration evidence; these are management claims rather than newly reported revenue, so company strength remains 6.9/10.
The lower USD 2.75 entry price raises price attractiveness to 5.5/10 under unchanged USD 4.32 / 1.28 cases. Company strength remains 6.7/10; risks from Atome and the planned USD 750m AI contribution are unchanged.
The lower USD 81.31 entry price raises price attractiveness to 6.9/10 at unchanged modeled prices of USD 233.04 / 43.30. Company strength remains 6.6/10; any equity funding at the lower price would dilute shareholders more, and its actual extent remains unverified.
The lower USD 12.48 entry price raises price attractiveness to 7.6/10 at unchanged three-year prices of USD 35 / 9. Company strength remains 7.2/10; the tokenization coalition and crypto survey do not yet establish incremental earnings.
At RBC, management clarified Preferred monetization, conversion timing and its cost intentions for 2027; the benefit of new consumer tools remains unquantified. Company strength remains 6.3/10; the lower USD 27.29 entry price improves scenario returns and price attractiveness to 4.0/10.
The lower entry price of $16.02 improves three-year scenario returns and raises price attractiveness to 4.8/10; company strength remains 5.1/10. The Peptides+ and UK metabolic program launches expand the offering, but adoption, margins and cash contribution have not yet been quantified.
Daily commentary The Correction Is Confirmed: AI Risk Collides with the Fed, but Bonds Warn of Weaker Growth Read article →
News from the Singularity Anthropic began trading on Nasdaq. Gemini adds Mac computer use and more efficient tool handling, Microsoft brings a small model to Edge, and research agents highlight the importance of checking results. Read article →
The lower USD 330.48 regular close improves the entry price, while the CMS CRUSH proposal intensifies Medicare Advantage audit risk; UNH-specific exposure is unquantified and the proposal is not final. The source therefore raises attractiveness to 6.7/10 with a harsher adverse scenario, while business strength remains 7.2/10.
The USD 14.41 November 19 regular close is 19.4% below the USD 17.87 price used in the latest completed assessment. The lower entry price raises attractiveness to 6.4/10 with unchanged scenarios; business strength remains 6.1/10 and financing and dilution remain major risks.
Q3 2026 earnings Q3 documented Connect growth to USD 4.3 billion and a 58% adjusted EBITDA margin, raising business strength to 7.3/10. Separately, the higher USD 26.06 entry price reduces attractiveness to 4.9/10; Kiavi returns and credit quality remain key tests.
The proxy statement newly quantifies potential dilution at 9.09%, grant burn rate around 6.2% and the SBC margin around 9.5%, clarifying per-share value risk. The lower USD 63.54 price improves returns, but strength of 5.3/10 and attractiveness of 4.0/10 remain unchanged.
Daily commentary Anthropic Succeeds, the Broader Market Does Not: Expensive Money Turns AI Euphoria into Broad-Based Risk Reduction Read article →
News from the Singularity Gemini 4 Neon and GPT-6.2 expand model choice as Google and Microsoft introduce long-running agents. Model ML funding and NVIDIA results show further development across applications and infrastructure. Read article →
New Bally’s filings confirm continuing liquidity risk; the USD 500 million second-lien financing commitment and another USD 60 million from GLPI for Chicago are not yet fully drawn. Strength and attractiveness remain 7.0/10 at USD 38.84: improved completion prospects are offset by increased exposure and continuing substantial doubt about going concern.
TCEQ resumed environmental review of data-center applications, easing one near-term obstacle; an impact on specific STRL contracts is not yet documented. Separately, the lower USD 275.26 entry price raises attractiveness to 7.2/10, while business strength remains 7.8/10.
Daily commentary Fed Links Further Rate Increases to the Risk of Opaque AI Financing Read article →